CHAMPION-AF Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3000 participants.
Also called NCT04394546
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 3,000 participants
- Sponsor
- Registry
-
NCT04394546
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Belgium, Canada, Denmark, France, Germany, Israel, Italy, Japan, Netherlands, Poland, Saudi Arabia, Spain, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04394546. Randomized; single masking; primary purpose prevention. Start 2020-10-15 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CHAMPION-AF Clinical Trial
- Acronym
- CHAMPION-AF
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Condition
- Bleeding
- Intervention (Device)
- WATCHMAN FLX LAAC Device
- Intervention (Drug)
- Non-Vitamin K Oral Anticoagulant
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct04394546- Content hash
c36328544e761d587505c8946e2306d5192e38242b348c7563b4db7e0185a352